New 52 Week Low Today

Applied Genetic Technologies Corp AGTC:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 6:50 PM EDT
0.29quote price arrow up+0.02 (+6.77%)
Volume
20,451
Close
0.2716quote price arrow down-0.0052 (-1.8786%)
Volume
1,388,681
52 week range
0.27 - 3.18
Loading...
  • Open0.2899
  • Day High0.308
  • Day Low0.27
  • Prev Close0.2768
  • 52 Week High3.18
  • 52 Week High Date11/18/21
  • 52 Week Low0.27
  • 52 Week Low Date09/30/22

Key Stats

  • Market Cap18.37M
  • Shares Out67.63M
  • 10 Day Average Volume0.74M
  • Dividend-
  • Dividend Yield-
  • Beta1.37
  • YTD % Change-85.71

KEY STATS

  • Open0.2899
  • Day High0.308
  • Day Low0.27
  • Prev Close0.2768
  • 52 Week High3.18
  • 52 Week High Date11/18/21
  • 52 Week Low0.27
  • 52 Week Low Date09/30/22
  • Market Cap18.37M
  • Shares Out67.63M
  • 10 Day Average Volume0.74M
  • Dividend-
  • Dividend Yield-
  • Beta1.37
  • YTD % Change-85.71

RATIOS/PROFITABILITY

  • EPS (TTM)-1.54
  • P/E (TTM)-0.18
  • Fwd P/E (NTM)-0.22
  • EBITDA (TTM)-64.338M
  • ROE (TTM)-119.60%
  • Revenue (TTM)330,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-21,153.85%
  • Debt To Equity (MRQ)62.49%

EVENTS

  • Earnings Date11/12/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Applied Genetic Technologies Corp

 

Profile

MORE
Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. The Company uses gene therapy platform to develop genetic therapies for patients suffering from rare and debilitating diseases. Its focus is in the field of ophthalmology where it has active clinical programs in X-linked retinitis pigmentosa (XLRP), achromatopsia (ACHM) and a optogenetics program, as well as a preclinical program in dry age-related macular degeneration (dAMD). It has...
Scott Koenig M.D., Ph.D.
Independent Chairman of the Board
Susan Washer
President, Chief Executive Officer, Director
Jonathan Lieber
Chief Financial Officer
Hope D'oyley-gay
General Counsel
Sarah Disalvatore
Vice President - Clinical Operations
Address
Suite D, 11801 Research Drive
Alachua, FL
32615
United States

Top Peers

SYMBOLLASTCHG%CHG
ELOX
Eloxx Pharmaceuticals Inc
0.17+0.0185+12.21%
SLNO
Soleno Therapeutics Inc
1.67+0.04+2.45%
NEXI
Neximmune Inc
0.5546-0.0034-0.6093%
FBRX
Forte Biosciences Inc
1.07+0.01+0.47%
OTIC
Otonomy Inc
0.295+0.0206+7.51%